RecruitingPhase 2NCT07201519

Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy

Studying Cholangiocarcinoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Michael J Cavnar, MD
Principal Investigator
Michael Cavnar, MD, M.D
University of Kentucky
Intervention
Hepatic Artery Infusion Pump (HAIP)(device)
Enrollment
80 enrolled
Eligibility
18-99 years · All sexes
Timeline
2026 – 2030

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07201519 on ClinicalTrials.gov

Other trials for Cholangiocarcinoma

Additional recruiting or active studies for the same condition.

See all trials for Cholangiocarcinoma →

← Back to all trials